The Pro Medicus Ltd (ASX: PME) share price is racing higher today. Here’s why investors are piling into the ASX 200 ...

Based on its current share price, this implies potential upside of 7.5% for investors over the next 12 months. It also ...

There may be questions surrounding Alphabet, but it has a robust business and is here to stay. At its current trading price, ...

As we reach the halfway mark in 2025, it's clear that artificial intelligence remains a dominant theme in the market.

Gold has been a strong asset for the year to date, supported by multiple tailwinds. Could Trump's budget bill send the gold ...

Investor interest in AI has surged as the technology continues to develop. Here are the ones to keep an eye on in FY26.

The leading broker has named these ASX 200 stocks as best buys this month. Here's why its analysts are bullish on ...

UBS currently has a buy rating and $9.30 price target on its shares. Another ASX dividend share that could be a buy is GQG ...

The "Magnificent Seven" are giants of the stock market. Which of these two will be the winning investment in the long run?

Consumer discretionary shares are impacted by interest rates. Here are two worth watching with upcoming RBA decisions in ...

UBS is bullish and has a buy rating and $215.00 price target on its shares. Get Started Investing You can do it. Learn about ...

Whilst healthcare stocks are often described as underrepresented on the ASX, these two growth options could be buy low ...